Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 9 of 9 for “"Chrysin"”.
-
Development of dry powder Inhaler and nebulised nanoparticles formulations of chrysin for the potential treatment of asthma. Development of dry powder inhaler of chrysin and nebulised nanoemulsion combination of chrysin and budesonide; Evaluating the anti-inflammatory activity of the combination formulation of chrysin and budesonide for asthma
Chrysin is a flavonoid that can be used as a medication for asthma and chronic obstructive pulmonary disease due to its anti-inflammatory activities. However, no studies have investigated the effectiveness of an inhaled formulation of chrysin on its own or in combination with corticosteroids. …
-
The effects of chrysin on osteoclastogenesis in RAW264.7 murine macrophages and bone metabolism in Sprague Dawley rats
… the potential beneficial effects on bone from chrysin, a bioactive phytochemical. Western blotting was carried out to assess the impact of chrysin on the RANK signalling pathways. Immunofluorescence was conducted to determine how chrysin effects the translocation of nuclear factor kappa B …
-
Condensation of terephthalaldehyde and hydroxyacetophenones
… period, von Kostanecki submitted to examination chrysin, a coloring matter which had been isolated from the bud of the common popular. From the properties of this substance and the fact that when hydrolyzed it yields acetophenone and phloroglucinol, von Kostanecki represented it as a dihydroxy …
-
SYNTHESIS AND CHARACTERIZATION OF RESVERATROL AND ITS CONJUGATED METABOLITES AND CONTRIBUTION OF METABOLISM TO ITS DECREASED BIOVAILABILITY
… with two dietary polyphenols (curcumin and chrysin) on two chemoprevention endpoints - i) antiproliferation and ii) UGT enzyme induction. Our results indicate that resveratrol is capable of inducing UGT1A1 expression and activity in a non-concentration dependent manner and this induction as …
-
A study of the toxicological properties of propolis samples from Europe and Saudi Arabia and of their biological activity against protozoa
… including 3-Acetoxypinobanksin (1), 7-Methoxychrysin (2), Kaempferol (3), Pinocembrin (4), 4'-Methoxykaempferol (5), Galangin (6), Chrysin (7), Apigenin (8), Pinostrobin (9), Cinnamic acid (10), Coumaric acid cinnamyl ester (11a) and Coumaric acid benzylester (11b). Two compounds were isolated …
-
Komplexkonjugate bioaktiver Flavonoide & Naphthochinone und Photoaktivierung von Carboplatin für Studien der intrazellulären Verteilung
… bidentate Flavonoidliganden wurden Wogonin (17), Chrysin (23), Apigenin (12), Genistein (13) und Xanthohumol (24) und als Naphthochinonliganden Juglon (38), Plumbagin (37) und dessen Derivate verwendet. In Zusammenarbeit mit dem Arbeitskreis von Prof. Dr. Rambold wurde Parietin (107) aus Flechten …
-
Computer-aided design and synthesis of 5,7-dihydroxyflavone derivatives as glycogen phosphorylase inhibitors
… compared these results to our benchmark ligand chrysin, which can inhibit glycogen phosphorylase with a Ki of 19.01 µm and identified thirteen ligands which are predicted to have better binding affinities exploiting a rigorous consensus scoring approach to reduce the chance of false positives. …
-
Science Based Authentication of Dietary Supplements: Studies on the Chemical Constituents, Analytical Method and Biological Activities of Scutellaria Spp and Pfaffia Paniculata
… such as baicalein, baicalin, wogonin, and chrysin etc. that provides some information on possible new application of skullcap, especially American skullcap, for the treatment of diabetic-related diseases. Also the potent activity of these flavonoids on PPARs suggests the potential of these …
-
Developing novel systems for expression of intracellular membrane-bound human cytochrome P450 enzymes in baker’s yeast
… (b) human CYP3A4 have been used to transform (i) chrysin, a natural product, (ii) codeine, a CYP2D6 substrate, and (ii) the CYP3A4 substrate, AZD-2014, an Astra-Zeneca drug in multicentre Phase II/Phase III clinical trials. The results from LC/MS, HPLC and TLCs clearly show that there is >80% …